Allogene Therapeutics, Inc. (ALLO)

NASDAQ: ALLO · IEX Real-Time Price · USD

2.830

-0.220 (-7.21%)

At close: Jul 19, 2024, 4:00 PM

2.840

+0.010 (0.35%)

Pre-market: Jul 22, 2024, 7:37 AM EDT

Allogene Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Revenue	0.07	0.1	0.16	114.09	0	0	Upgrade
Revenue Growth (YoY)	-48.00%	-39.10%	-99.86%	-	-	-	Upgrade
Gross Profit	0.07	0.1	0.16	114.09	0	0	Upgrade
Selling, General & Admin	70.06	71.67	79.31	74.11	65.26	57.47	Upgrade
Research & Development	214.94	242.91	256.39	220.18	192.99	144.54	Upgrade
Other Operating Expenses	13.25	13.25	0	0	0	0	Upgrade
Operating Expenses	298.24	327.83	335.69	294.28	258.24	202.01	Upgrade
Operating Income	-298.17	-327.74	-335.54	-180.19	-258.24	-202.01	Upgrade
Other Expense / Income	-4.61	-0.47	4.88	1.86	58.14	-17.08	Upgrade
Pretax Income	-293.56	-327.27	-340.41	-182.05	-316.38	-184.93	Upgrade
Income Tax	0	0	0	0	0	-0.33	Upgrade
Net Income	-293.56	-327.27	-340.41	-182.05	-316.38	-184.59	Upgrade
Shares Outstanding (Basic)	169	157	143	136	120	101	Upgrade
Shares Outstanding (Diluted)	169	157	143	136	120	101	Upgrade
Shares Change	16.99%	9.63%	5.39%	12.84%	19.11%	249.11%	Upgrade
EPS (Basic)	-1.82	-2.09	-2.38	-1.34	-2.63	-1.83	Upgrade
EPS (Diluted)	-1.82	-2.09	-2.38	-1.34	-2.63	-1.83	Upgrade
Free Cash Flow	-227.48	-239.25	-225.71	-206.26	-181.05	-188.14	Upgrade
Free Cash Flow Per Share	-1.34	-1.52	-1.58	-1.52	-1.50	-1.86	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	-	-	Upgrade
Operating Margin	-458724.62%	-344986.32%	-215087.18%	-157.94%	-	-	Upgrade
Profit Margin	-451632.31%	-344489.47%	-218214.10%	-159.57%	-	-	Upgrade
Free Cash Flow Margin	-349972.31%	-251841.05%	-144685.90%	-180.79%	-	-	Upgrade
EBITDA	-279.31	-313.07	-326.12	-171.6	-308.95	-180.5	Upgrade
EBITDA Margin	-429713.85%	-329543.16%	-209050.64%	-150.41%	-	-	Upgrade
Depreciation & Amortization	14.25	14.2	14.3	10.45	7.44	4.42	Upgrade
EBIT	-293.56	-327.27	-340.41	-182.05	-316.38	-184.93	Upgrade
EBIT Margin	-451632.31%	-344489.47%	-218214.10%	-159.57%	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).